A detailed history of Act Capital Management, LLC transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Act Capital Management, LLC holds 27,500 shares of BLRX stock, worth $6,050. This represents 0.03% of its overall portfolio holdings.

Number of Shares
27,500
Previous 27,500 -0.0%
Holding current value
$6,050
Previous $35,000 28.57%
% of portfolio
0.03%
Previous 0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

BUY
$2.63 - $4.88 $72,325 - $134,200
27,500 New
27,500 $78,000

Others Institutions Holding BLRX

About BioLineRx Ltd.


  • Ticker BLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,524,500
  • Market Cap $13.5M
  • Description
  • BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...
More about BLRX
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.